Obesity drugs
Novo says higher-dose Wegovy drove nearly 28% weight loss in some patients
The new analysis comes a month after the 7.2-milligram Wegovy dose launched in the U.S., as Novo Nordisk works to compete more directly with Eli Lilly’s Zepbound